Gene therapy in cardiovascular disorder market is estimated to be worth US$ 178 million in 2023 and is projected to reach US$ 1,351.3 million by 2030, growing at a CAGR of 21.1% during the forecast period 2024-2030. This significant growth is driven by factors such as rising prevalence of cardiovascular diseases, increasing investments in gene therapy research and development, and growing...

Market Overview Gene therapy is a medical field focused on modifying or replacing faulty genes to treat or prevent disease. This revolutionary treatment modality targets the root cause of various disorders, from inherited genetic defects to cancers and infectious diseases. Technologies within this domain include adeno-associated virus vectors (AAVs), lentiviral vectors, CRISPR-Cas9,...